Brain Implants Market By Type | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Brain Implants Market
Brain Implants Market: By Type (Deep Brain Stimulator (DBS), Vagus Nerve Stimulator (VNS) and Spinal Cord Stimulator (SCS)); and By Geography (Europe, APAC, North America and Rest of the World) - Forecast (2016-2021)
Report Code : HCR 0163
Published: 22 March, 2016   No. of pages: 155

  • Report Description
  • Table of Contents
  • Customization Options
Brain implants, also referred as neural implants are connected directly to the brain either by placing on the brain surface i.e., over gyri and sulci, or they are attached to the cortex of brain. When brain becomes dysfunction because of various reasons such as head injuries and stroke, brain implants are used. Brain implants electrically stimulate, block, record or both record and stimulate simultaneously signals from single neurons or groups of neurons in the brain. Globally, growing incidences of various neurological disorders especially Parkinson's disease, rise in aging population, and increasing prevalence of major depressive disorder are the prime growth drivers of brain implants market. In addition, technological advancements and emerging economies such as China, India and others, will create new opportunities for brain implants market. However, higher cost of the device, complexity of neural processing, and safety concerns are the key restraints for brain implants market.

This report identifies the global brain implants market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global brain implants market.
 
Brain Implants Market

Geographically North America dominated brain implants market, due to presence of a large number of manufacturers of brain implants in the region coupled with high disposable income of the population. Asia Pacific is projected to have fastest growth, owing to rapidly increasing aging population, rising disposable income in the countries such as China and India, and modernizing healthcare infrastructure in this region. Among all the types, Deep Brain Stimulator (DBS) segment has the highest market share in brain implants market because of their high efficiency in the treatment of Parkinson’s disease. Vagus Nerve Stimulators (VNS) are forecast to have a significant growth owing to their higher usage for partial treatment of onset epilepsy

This report segments brain implants market on the basis of type, and regional market as follows:
  • Brain Implants Market, By Type: Deep Brain Stimulator (DBS), Vagus Nerve Stimulator (VNS), and Spinal Cord Stimulator (SCS)
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the brain implants market. Some of the major companies’ profiles in detail are as follows:
  • Boston Scientific Corporation
  • St Jude Medical, Inc.
  • MEDTRONIC, Inc.
  • Aleva Neurotherapeutics SA
  • Sapiens Neuro
1. Brain Implants – Market Overview
2. Executive Summary 
3. Brain Implants Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Brain Implants Market– Market Forces
   4.1. Drivers
      4.1.1. Growing incidences of various neurological disorders especially Parkinson's disease
      4.1.2. Rise in aging population
      4.1.3. Increasing prevalence of major depressive disorder
   4.2. Restraints
      4.2.1. Cost of devices is high
      4.2.2. Complexity of neural processing 
      4.2.3. Safety concerns
   4.3. Opportunities
      4.3.1. Emerging economies
      4.3.2. Technological advancements
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Brain Implants Market, By Type 
   5.1. Deep Brain Stimulator (DBS)
   5.2. Vagus Nerve Stimulator (VNS)
   5.3. Spinal Cord Stimulator (SCS) 
6. Brain Implants Market, By Geography
   6.1. Europe
      6.1.1. Germany
      6.1.2. France
      6.1.3. Italy
      6.1.4. Spain
      6.1.5. Russia
      6.1.6. U.K.
      6.1.7. Rest of Europe
   6.2. Asia Pacific
      6.2.1. China
      6.2.2. India
      6.2.3. Japan
      6.2.4. South Korea
      6.2.5. Rest of Asia-Pacific
   6.3. North America 
      6.3.1. U.S.
      6.3.2. Canada
      6.3.3. Mexico
   6.4. Rest of the World (RoW)
      6.4.1. Brazil
      6.4.2. Rest of RoW
7. Brain Implants – Market Entropy
   7.1. Expansion
   7.2. Technological Developments
   7.3. Merger & Acquisitions, and Joint Ventures
   7.4. Supply- Contract
8. Company Profiles
   8.1. Boston Scientific Corporation
      8.1.1. Introduction
      8.1.2. Financials
      8.1.3. Key Insights
      8.1.4. Key Strategy
      8.1.5. Product Portfolio
      8.1.6. SWOT Analysis
   8.2. St Jude Medical, Inc.
      8.2.1. Introduction
      8.2.2. Financials
      8.2.3. Key Insights
      8.2.4. Key Strategy
      8.2.5. Product Portfolio
      8.2.6. SWOT Analysis
   8.3. MEDTRONIC, Inc.
      8.3.1. Introduction
      8.3.2. Financials
      8.3.3. Key Insights
      8.3.4. Key Strategy
      8.3.5. Product Portfolio
      8.3.6. SWOT Analysis
   8.4. Aleva Neurotherapeutics SA
      8.4.1. Introduction
      8.4.2. Financials
      8.4.3. Key Insights
      8.4.4. Key Strategy
      8.4.5. Product Portfolio
      8.4.6. SWOT Analysis
   8.5. Sapiens Neuro
      8.5.1. Introduction
      8.5.2. Financials
      8.5.3. Key Insights
      8.5.4. Key Strategy
      8.5.5. Product Portfolio
      8.5.6. SWOT Analysis
   8.6. Edwards Lifesciences Corporation
      8.6.1. Introduction
      8.6.2. Financials
      8.6.3. Key Insights
      8.6.4. Key Strategy
      8.6.5. Product Portfolio
      8.6.6. SWOT Analysis
   8.7. Terumo Corporation
      8.7.1. Introduction
      8.7.2. Financials
      8.7.3. Key Insights
      8.7.4. Key Strategy 
      8.7.5. Product Portfolio
      8.7.6. SWOT Analysis
   8.8. Cochlear, Ltd.
      8.8.1. Introduction
      8.8.2. Financials
      8.8.3. Key Insights
      8.8.4. Key Strategy
      8.8.5. Product Portfolio
      8.8.6. SWOT Analysis
   8.9. Abiomed, Inc.
      8.9.1. Introduction
      8.9.2. Financials
      8.9.3. Key Insights
      8.9.4. Key Strategy
      8.9.5. Product Portfolio
      8.9.6. SWOT Analysis
   8.10. Ekso Bionics
      8.10.1. Introduction
      8.10.2. Financials
      8.10.3. Key Insights
      8.10.4. Key Strategy
      8.10.5. Product Portfolio
      8.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
9. Appendix
   9.1. Abbreviations
   9.2. Sources
   9.3. Research Methodology
   9.4. Bibliography
   9.5. Compilation of Expert Insights
   9.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports